| Quarter | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| 27 | 31 | 31 | 45 | |
Growth YoY Revenue Growth YoY% | 11.0 | 45.4 | ||
| 23 | 26 | 25 | 36 | |
| 5 | 4 | 5 | 8 | |
OPM OPM% | 17.0 | 14.3 | 17.5 | 18.6 |
| 0 | 0 | 0 | 1 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 |
PBT PBTCr | 5 | 4 | 5 | 8 |
| 0 | 1 | 0 | 0 | |
| 5 | 3 | 5 | 8 | |
Growth YoY PAT Growth YoY% | 7.5 | 205.2 | ||
NPM NPM% | 16.4 | 8.7 | 15.9 | 18.3 |
| 0.0 | 0.0 | 0.0 | 12.5 |
| Quarter | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| 27 | 31 | 31 | 45 | |
Growth YoY Revenue Growth YoY% | 11.0 | 45.4 | ||
| 23 | 26 | 25 | 36 | |
| 5 | 4 | 5 | 8 | |
OPM OPM% | 17.0 | 14.3 | 17.5 | 18.6 |
| 0 | 0 | 0 | 1 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 |
PBT PBTCr | 5 | 4 | 5 | 8 |
| 0 | 1 | 0 | 0 | |
| 5 | 3 | 5 | 8 | |
Growth YoY PAT Growth YoY% | 7.5 | 205.2 | ||
NPM NPM% | 16.4 | 8.7 | 15.9 | 18.3 |
| 0.0 | 0.0 | 0.0 | 12.5 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
Revenue RevenueCr | 40 | 23 | 28 | 58 | 75 |
Growth Revenue Growth% | -42.5 | 18.4 | 111.7 | 29.2 | |
| 38 | 20 | 22 | 49 | 62 | |
| 2 | 4 | 5 | 9 | 14 | |
OPM OPM% | 5.6 | 15.3 | 19.1 | 15.6 | 18.2 |
| 0 | 0 | 0 | 0 | ||
Interest Expense Interest ExpenseCr | 0 | 0 | 1 | 0 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 |
PBT PBTCr | 2 | 3 | 5 | 9 | 13 |
| 1 | 1 | 2 | 0 | 0 | |
PAT PATCr | 1 | 2 | 3 | 9 | 13 |
Growth PAT Growth% | 14.2 | 73.7 | 193.4 | 51.4 | |
NPM NPM% | 3.7 | 7.3 | 10.7 | 14.8 | 17.3 |
| 4.9 | 4.7 | 7.1 | 14.1 | 20.1 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
Revenue RevenueCr | 40 | 23 | 28 | 58 | 75 |
Growth Revenue Growth% | -42.5 | 18.4 | 111.7 | 29.2 | |
| 38 | 20 | 22 | 49 | 62 | |
| 2 | 4 | 5 | 9 | 14 | |
OPM OPM% | 5.6 | 15.3 | 19.1 | 15.6 | 18.2 |
| 0 | 0 | 0 | 0 | ||
Interest Expense Interest ExpenseCr | 0 | 0 | 1 | 0 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 |
PBT PBTCr | 2 | 3 | 5 | 9 | 13 |
| 1 | 1 | 2 | 0 | 0 | |
PAT PATCr | 1 | 2 | 3 | 9 | 13 |
Growth PAT Growth% | 14.2 | 73.7 | 193.4 | 51.4 | |
NPM NPM% | 3.7 | 7.3 | 10.7 | 14.8 | 17.3 |
| 4.9 | 4.7 | 7.1 | 14.1 | 20.1 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
Equity Capital Equity CapitalCr | 0 | 4 | 5 | 6 |
Reserves ReservesCr | 2 | 2 | 10 | 24 |
| 4 | 6 | 7 | 7 | |
| 0 | 1 | 1 | 3 | |
| 6 | 13 | 23 | 40 | |
| 4 | 11 | 21 | 36 | |
| 2 | 2 | 2 | 4 | |
| 6 | 13 | 23 | 40 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
Equity Capital Equity CapitalCr | 0 | 4 | 5 | 6 |
Reserves ReservesCr | 2 | 2 | 10 | 24 |
| 4 | 6 | 7 | 7 | |
| 0 | 1 | 1 | 3 | |
| 6 | 13 | 23 | 40 | |
| 4 | 11 | 21 | 36 | |
| 2 | 2 | 2 | 4 | |
| 6 | 13 | 23 | 40 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| 1 | -4 | -5 | -6 | -1 | |
| -2 | 0 | 0 | -2 | -3 | |
| 2 | 4 | 5 | 8 | 28 | |
Net Cash Flow Net Cash FlowCr | 0 | 0 | 0 | 1 | 24 |
Free Cash Flow Free Cash FlowCr | -1 | -4 | -5 | -6 | |
CFO To PAT CFO To PAT% | 54.5 | -249.6 | -163.6 | -67.3 | -9.8 |
CFO To EBITDA CFO To EBITDA% | 35.4 | -118.2 | -91.2 | -63.7 | -9.4 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| 1 | -4 | -5 | -6 | -1 | |
| -2 | 0 | 0 | -2 | -3 | |
| 2 | 4 | 5 | 8 | 28 | |
Net Cash Flow Net Cash FlowCr | 0 | 0 | 0 | 1 | 24 |
Free Cash Flow Free Cash FlowCr | -1 | -4 | -5 | -6 | |
CFO To PAT CFO To PAT% | 54.5 | -249.6 | -163.6 | -67.3 | -9.8 |
CFO To EBITDA CFO To EBITDA% | 35.4 | -118.2 | -91.2 | -63.7 | -9.4 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 130 | |||||
Price To Earnings Price To Earnings | 11.8 | |||||
Price To Sales Price To Sales | 1.7 | |||||
Price To Book Price To Book | 1.8 | |||||
EV To EBITDA EV To EBITDA | 8.3 | |||||
GPM GPM% | 13.0 | 29.4 | 33.6 | 27.4 | ||
OPM OPM% | 5.6 | 15.3 | 19.1 | 15.6 | 18.2 | 18.2 |
NPM NPM% | 3.7 | 7.3 | 10.7 | 14.8 | 17.3 | 17.3 |
ROCE ROCE% | 69.6 | 34.6 | 28.8 | 25.8 | ||
ROE ROE% | 76.6 | 28.8 | 19.5 | 28.3 | ||
ROA ROA% | 25.6 | 12.7 | 12.9 | 21.5 | ||
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 130 | |||||
Price To Earnings Price To Earnings | 11.8 | |||||
Price To Sales Price To Sales | 1.7 | |||||
Price To Book Price To Book | 1.8 | |||||
EV To EBITDA EV To EBITDA | 8.3 | |||||
GPM GPM% | 13.0 | 29.4 | 33.6 | 27.4 | ||
OPM OPM% | 5.6 | 15.3 | 19.1 | 15.6 | 18.2 | 18.2 |
NPM NPM% | 3.7 | 7.3 | 10.7 | 14.8 | 17.3 | 17.3 |
ROCE ROCE% | 69.6 | 34.6 | 28.8 | 25.8 | ||
ROE ROE% | 76.6 | 28.8 | 19.5 | 28.3 | ||
ROA ROA% | 25.6 | 12.7 | 12.9 | 21.5 | ||
Documents — Speciality Medicines Ltd